Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms

• US 8,936,810 B2
• Filed: 10/18/2012
• Issued: 01/20/2015
• Est. Priority Date: 06/03/1998
• Status: Expired due to Fees

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Stone, Steven F., Geerke, Johan H.
• Primary Examiner(s): Padmanabhan, Sreeni
• Assistant Examiner(s): KAROL, JODY LYNN
• Application Number:
  US13/654,958
• Publication Number:
  US 20130043612A1
• Time in Patent Office: 824 Days
• Field of Search: 424/461, 424/473, 356/402
• US Class Current: 424/473
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: A61P 25/14 for treating abnormal movements, e.g. chorea, dyskinesia
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: G01N 21/9508 Capsules; Tablets

Abstract

Rapid and accurate determination of the formulation orientation of multi-layer capsule-shaped tablets with respect to different internal formulation layers proximate to the opposite narrow and rounded ends of the tablets is required. By including an appropriate color scheme in multi-layer osmotic tablets, detection of the formulation orientation is achieved by detecting the color at a spot location on a side of the tablet corresponding to one or another formulation layer or to one or another interface of two formulation layers depending on the formulation orientation of the tablet.

Claims

1. A method of preparing a capsule-shaped tablet having a push end and a dispensing end for laser drilling of a delivery port in said dispensing end, wherein the tablet comprises adjacent first and second formulation layers each containing methylphenidate or a pharmaceutically acceptable salt thereof, and a further formulation layer not containing methylphenidate or a pharmaceutically acceptable salt thereof and being located at the push end of the tablet,

the method comprising the steps of:

detecting the formulation orientation of the tablet by detecting the color at a spot location on a side of the tablet corresponding to one or another formulation layer depending on the formulation orientation of the tablet, wherein at least one layer contains a colorant;

determining the formulation orientation of the tablet on the basis of the color detected;

passing the tablets through a tablet rectifier wherein the orientation of any improperly oriented tablets is rectified and the orientation of any properly oriented tablets is maintained; and

collecting the uniformly oriented tablets from said tablet rectifier for transportation to a laser drilling station.

2. The method of claim 1 wherein the colorant is a dark colorant.

3. The method of claim 2 wherein the formulation layer containing the dark colorant does not contain methylphenidate or a pharmaceutically acceptable salt thereof and another formulation layer containing methylphenidate or a pharmaceutically acceptable salt thereof also contains a light colorant.

5. The method of claim 1 wherein the formulation layer containing the colorant does not contain methylphenidate or a pharmaceutically acceptable salt thereof and another formulation layer containing methylphenidate or a pharmaceutically acceptable salt thereof also contains a lighter colorant.

6. The method of claim 1 wherein the formulation layer containing the colorant contains methylphenidate or a pharmaceutically acceptable salt thereof and another formulation layer that does not contain methylphenidate or a pharmaceutically acceptable salt thereof contains a lighter colorant.

7. The method of claim 1 wherein the formulation layer containing the colorant contains methylphenidate or a pharmaceutically acceptable salt thereof and another formulation layer that does not contain methylphenidate or a pharmaceutically acceptable salt thereof does not contain a colorant.

4. A method of making a multi-layer tablet having a pushing end and a dispensing end, wherein the tablet comprises adjacent first and second formulation layers each containing a drug ingredient, and a further formulation layer not containing a drug ingredient and being located at the push end of the tablet, comprising:

adding a first colorant to one formulation layer containing methylphenidate or a pharmaceutically acceptable salt thereof proximately positioned at the dispensing end of the multi-layered tablet, the first colorant being complementary to no color;

adding a second colorant to at least one formulation layer not containing any methylphenidate or a pharmaceutically acceptable salt thereof proximately positioned at the push end of the multi-layered tablet, the second colorant distinguishable from the first colorant or from no color;

compressing the formulation layers into a capsule-shaped osmotic tablet such that the formulation orientation of the tablet can be determined by detecting the color at a spot location on a side of the tablet corresponding to one or another differently-colored formulation layer depending on the formulation orientation of the tablet, and

detecting the formulation orientation of the tablet with a color detector directed at a spot location on a side of the tablet.